Market Spotlight – Report Special Offers
20% Discount off all Market Spotlight Reports – user discount code: marketspotlight20 at checkout!
Market Spotlight: Hypogonadism$1,318.00
The approved drugs in the hypogonadism space target androgen receptors, estrogen receptor alpha, and estrogen receptor beta. These are commonly administered via the transdermal route, with a smaller number of products being available in oral, intramuscular, intranasal, sublingual/oral transmucosal, subcutaneous, and topical formulations.November 18, 2022
Market Spotlight: Systemic Lupus Erythematosus (SLE)$1,318.00
This Market Spotlight report covers the Systemic Lupus Erythematosus (SLE) market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory events, probability of success, epidemiology information, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.November 3, 2022